Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Proinflammatory Pathways in the Pathogenesis of Asthma.

Peebles RS Jr, Aronica MA.

Clin Chest Med. 2019 Mar;40(1):29-50. doi: 10.1016/j.ccm.2018.10.014. Review.

PMID:
30691715
2.

The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.

Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS Jr, Graham BS, Moore ML, Anderson LJ, Wright ER.

Viruses. 2018 Aug 20;10(8). pii: E446. doi: 10.3390/v10080446.

3.

Prostaglandins in asthma and allergic diseases.

Peebles RS Jr.

Pharmacol Ther. 2019 Jan;193:1-19. doi: 10.1016/j.pharmthera.2018.08.001. Epub 2018 Aug 3. Review.

PMID:
30081047
4.

Association of ST2 polymorphisms with atopy, asthma, and leukemia.

Bloodworth MH, Rusznak M, Bastarache L, Wang J, Denny JC, Peebles RS Jr.

J Allergy Clin Immunol. 2018 Sep;142(3):991-993.e3. doi: 10.1016/j.jaci.2018.03.020. Epub 2018 May 19. No abstract available.

PMID:
29787780
5.

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Bloodworth MH, Rusznak M, Pfister CC, Zhang J, Bastarache L, Calvillo SA, Chappell JD, Boyd KL, Toki S, Newcomb DC, Stier MT, Zhou W, Goleniewska K, Moore ML, Hartert TV, Niswender KD, Peebles RS Jr.

J Allergy Clin Immunol. 2018 Aug;142(2):683-687.e12. doi: 10.1016/j.jaci.2018.01.053. Epub 2018 Apr 17. No abstract available.

PMID:
29678751
6.

Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model.

Toki S, Zhou W, Goleniewska K, Reiss S, Dulek DE, Newcomb DC, Lawson WE, Peebles RS Jr.

Prostaglandins Other Lipid Mediat. 2018 May;136:33-43. doi: 10.1016/j.prostaglandins.2018.04.001. Epub 2018 Apr 13.

7.

Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.

Toki S, Goleniewska K, Reiss S, Zhang J, Bloodworth MH, Stier MT, Zhou W, Newcomb DC, Ware LB, Stanwood GD, Galli A, Boyd KL, Niswender KD, Peebles RS Jr.

J Allergy Clin Immunol. 2018 Nov;142(5):1515-1528.e8. doi: 10.1016/j.jaci.2017.11.043. Epub 2018 Jan 10.

PMID:
29331643
8.

IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow.

Stier MT, Zhang J, Goleniewska K, Cephus JY, Rusznak M, Wu L, Van Kaer L, Zhou B, Newcomb DC, Peebles RS Jr.

J Exp Med. 2018 Jan 2;215(1):263-281. doi: 10.1084/jem.20170449. Epub 2017 Dec 8.

9.

STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

Stier MT, Goleniewska K, Cephus JY, Newcomb DC, Sherrill TP, Boyd KL, Bloodworth MH, Moore ML, Chen K, Kolls JK, Peebles RS Jr.

J Immunol. 2017 Jul 15;199(2):510-519. doi: 10.4049/jimmunol.1601984. Epub 2017 Jun 2.

10.

Is IL-1β inhibition the next therapeutic target in asthma?

Peebles RS Jr.

J Allergy Clin Immunol. 2017 Jun;139(6):1788-1789. doi: 10.1016/j.jaci.2017.03.018. Epub 2017 Apr 8. No abstract available.

PMID:
28396074
11.

Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence.

Hines KL, Peebles RS Jr.

Curr Allergy Asthma Rep. 2017 Mar;17(3):15. doi: 10.1007/s11882-017-0683-4. Review.

PMID:
28283854
12.

Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.

Stier MT, Bloodworth MH, Toki S, Newcomb DC, Goleniewska K, Boyd KL, Quitalig M, Hotard AL, Moore ML, Hartert TV, Zhou B, McKenzie AN, Peebles RS Jr.

J Allergy Clin Immunol. 2016 Sep;138(3):814-824.e11. doi: 10.1016/j.jaci.2016.01.050. Epub 2016 Apr 9.

13.

STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection.

Bloodworth MH, Newcomb DC, Dulek DE, Stier MT, Cephus JY, Zhang J, Goleniewska K, Kolls JK, Peebles RS Jr.

Infect Immun. 2016 Apr 22;84(5):1548-1555. doi: 10.1128/IAI.00646-15. Print 2016 May.

14.

Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).

Larkin EK, Gebretsadik T, Moore ML, Anderson LJ, Dupont WD, Chappell JD, Minton PA, Peebles RS Jr, Moore PE, Valet RS, Arnold DH, Rosas-Salazar C, Das SR, Polack FP, Hartert TV; INSPIRE Study.

BMC Pulm Med. 2015 Apr 30;15:45. doi: 10.1186/s12890-015-0040-0.

15.

At the bedside: the emergence of group 2 innate lymphoid cells in human disease.

Peebles RS Jr.

J Leukoc Biol. 2015 Mar;97(3):469-75. doi: 10.1189/jlb.3BT0814-383R. Epub 2014 Dec 16. Review.

16.

Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.

Dulek DE, Newcomb DC, Goleniewska K, Cephus J, Zhou W, Reiss S, Toki S, Ye F, Zaynagetdinov R, Sherrill TP, Blackwell TS, Moore ML, Boyd KL, Kolls JK, Peebles RS Jr.

Infect Immun. 2014 Sep;82(9):3723-39. doi: 10.1128/IAI.00035-14. Epub 2014 Jun 23.

17.

STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.

Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE Jr, Boyd KL, Moore ML, Zhou W, Peebles RS Jr.

J Virol. 2014 Sep 1;88(17):9655-72. doi: 10.1128/JVI.03299-13. Epub 2014 Jun 11.

18.

A new horizon in asthma: inhibiting ILC function.

Peebles RS Jr.

Sci Transl Med. 2013 Feb 27;5(174):174fs7. doi: 10.1126/scitranslmed.3005881. Review.

PMID:
23447016
19.

Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.

Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, Huckabee MM, Lee S, Goleniewska K, Pretto C, Williams JV, Hotard A, Sherrill TP, Peebles RS Jr, Moore ML.

J Virol. 2011 Jun;85(12):5782-93. doi: 10.1128/JVI.01693-10. Epub 2011 Apr 6.

20.

Novel concepts in virally induced asthma.

Huckabee MM, Peebles RS Jr.

Clin Mol Allergy. 2009 Jan 20;7:2. doi: 10.1186/1476-7961-7-2.

21.

Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.

Peebles RS Jr, Hashimoto K, Sheller JR, Moore ML, Morrow JD, Ji S, Elias JA, Goleniewska K, O'neal J, Mitchell DB, Graham BS, Zhou W.

J Immunol. 2005 Dec 15;175(12):8253-9.

22.

The complex relationship between respiratory syncytial virus and allergy in lung disease.

Peebles RS Jr, Hashimoto K, Graham BS.

Viral Immunol. 2003;16(1):25-34. Review.

PMID:
12725686
23.

Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice.

Peebles RS Jr, Hashimoto K, Morrow JD, Dworski R, Collins RD, Hashimoto Y, Christman JW, Kang KH, Jarzecka K, Furlong J, Mitchell DB, Talati M, Graham BS, Sheller JR.

Am J Respir Crit Care Med. 2002 Apr 15;165(8):1154-60.

PMID:
11956061
24.

Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV.

Peebles RS Jr, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS.

J Infect Dis. 2000 Sep;182(3):671-7. Epub 2000 Aug 4.

PMID:
10950758

Supplemental Content

Loading ...
Support Center